Chemtura Announces Receipt Of Requisite Consents For Consent Solicitation For Outstanding 7.875% Senior Notes Due 2018
Chemtura Corporation (NYSE: CHMT) (“Chemtura” or the “Company”)
announced today that it has received, pursuant to its previously
announced cash tender offer and consent solicitation with respect to any...
Chemtura Corporation (NYSE: CHMT) (“Chemtura” or the “Company”) announced today that it has received, pursuant to its previously announced cash tender offer and consent solicitation with respect to any and all of its outstanding $455.0 million aggregate principal amount of 7.875% Senior Notes due 2018 (the “Notes”), the requisite consents to adopt proposed amendments (the “Proposed Amendments”) to the indenture governing the Notes (the “Indenture”) that would eliminate substantially all of the restrictive covenants, certain events of default and related provisions contained therein. The Company announced that as of 5:00 p.m., New York City time, on June 21, 2013 (the “Consent Date”), tenders and consents had been delivered with respect to $348,346,000 aggregate principal amount of Notes, representing approximately 76.56% of the outstanding aggregate principal amount of Notes. In conjunction with receiving the requisite consents, the Company, the applicable guarantors and U.S. Bank National Association, as trustee, executed a supplemental indenture with respect to the Indenture implementing the Proposed Amendments. The supplemental indenture became effective upon execution, but the Proposed Amendments will not become operative unless and until the Company accepts the Notes for purchase pursuant to the terms and conditions described in the Offer to Purchase (as defined below). The tender offer and consent solicitation are being made on the terms and subject to the conditions set forth in the Company’s Offer to Purchase and Consent Solicitation Statement, dated June 10, 2013 (the “Offer to Purchase”). The tender offer and consent solicitation are subject to the satisfaction or waiver of certain conditions that are more fully described in the Offer to Purchase, including, among others, the consummation of a future offering of unsecured senior debt securities by the Company, on terms and conditions acceptable to the Company, in its sole discretion, yielding net proceeds in an amount sufficient to fund all of its obligations under the tender offer and consent solicitation.